Stocks @ Night is a daily newsletter delivered after hours, giving you the first information about tomorrow and the last information about today. Sign up for free to receive it straight to your inbox. As semiconductor stocks resume their slide, here’s what CNBC TV producers were watching and what they’re eyeing for the next deal. Oracle The tech giant will report after the bell on Wednesday. Oracle is up nearly 36% in the past three months. CNBC options reporter Oliver Rennick reported Tuesday that the implied move before the earnings release was 12%. This means that based on past post-earnings movements, investors believe the stock could move up or down by 12% after the report. Rennick also reported that call buys outnumbered puts by a 2-to-1 margin on Tuesday. CNBC’s Seema Modi gets the numbers as they cross in instant stock reaction after the bell. ORCL 3M Mountain Oracle Over the Past 3 Months “I like the pharmaceutical stocks here,” Jim Cramer of the pharmaceutical sector said on “Mad Money” Tuesday night. S&P Healthcare rose 1.3% on Tuesday. It has fallen 3.5% from February’s high. The S&P Pharma, Biotechnology, Life Sciences industry gained 8.6% over the past month. Mr. Kramer recently acquired Johnson & Johnson for a charting trust. The stock has risen 6% since he purchased it on June 1st. The stock has fallen 6% from its March 2 high. The stock price has increased about 53% in one year. Target’s CNBC Fast Money Trader Guy Adami noted on Tuesday night’s big show that the stock is up 52% from its November lows. Target rose 2% on Tuesday, but is now down 5% from its April 21 high. Italy’s CNBC data guru Gina Francola and “Morning Call” anchor Morgan Brennan toured Italy on Tuesday. The iShares MSCI Italy ETF (EWI), which tracks Italy’s biggest stocks including Ferrari, defense and aerospace company Leonardo, Telecom Italia and a group of Italian banks, hit a new high on Tuesday. EWI rose 2.5% at one point during trading, but rose only 1.5% on the day. The ETF is up 11% in three months. Mr. Brennan will make more investments in the ETF during a “wake-up call” starting Wednesday at 5 a.m. ET. CNBC’s Brandon Gomez, whose cannabis is one of Trulieve’s beats, will report on Wednesday that Trulieve has become the first U.S. cannabis company to go public on the New York Stock Exchange. This follows recent federal changes regarding cannabis, which could free up significant investor money into the industry. The stock hit a new high on Tuesday morning, but has since taken a deep dive. That’s totally disappointing. The stock price fell 11%. The stock is up 24% since the beginning of June. There are many good and bad things about this. The new ticker will be TRLV.
